AHNS Series - Do you know your guidelines? Lip cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28580768.
- Also identified by DOI 10.1002/hed.24817.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Lip cancer is one of the most curable primary head and neck malignancies, as the prominent location typically lends to an early diagnosis. The incidence of lip cancer varies by sex, ethnicity, and region, but is estimated to be up to 2.5/100 000 in the United States (squamous cell carcinoma [SCC]). This article will review the current literature and National Comprehensive Cancer Network practice guidelines in the treatment of lip cancer. Resection of lip cancer with negative margins remains the mainstay of therapy. Positive nodal disease should be treated with neck dissection and adjuvant radiotherapy. Lip cancer remains highly curable when diagnosed at an early stage. A multidisciplinary approach is crucial to treating patients with advanced-stage lip cancer.
Medical subject headings
- Carcinoma, Squamous Cell
- Lip Neoplasms
- Neck Dissection
- Practice Guidelines as Topic
- Radiotherapy, Adjuvant